Pro-Dex (PDEX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PDEX Pro-Dex

Watchlist

45.910
-3.390-6.88%

Close Dec 30 16:00 ET

45.910
0.0000.00%

Post 20:01 ET

149.64MMarket Cap30.20P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Pro Dex Inc - Maturity Date of $7 Million Revolving Loan Extended to Dec 29, 2026
ReutersDec 27 16:03 ET
Express News | Pro Dex Inc - Pro-Dex Enters Amendment No. 5 to Credit Agreement
ReutersDec 27 16:03 ET
Pro-Dex, Inc.'s (NASDAQ:PDEX) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Yahoo FinanceDec 3 11:25 ET
Pro-Dex Grants Restricted Shares to Key Executives
TipRanksNov 25 16:54 ET
One Analyst's Earnings Estimates For Pro-Dex, Inc. (NASDAQ:PDEX) Are Surging Higher
Yahoo FinanceNov 13 05:16 ET
Express News | Ascendiant Capital Maintains Buy on Pro-Dex, Raises Price Target to $52
BenzingaNov 11 04:44 ET

Comments

Stock_Drift

Nov 1 10:33

Unusual Volume Ticks. 11:32am

$Madrigal Pharmaceuticals (MDGL.US)$ $Nuburu (BURU.US)$ $Pro-Dex (PDEX.US)$ $ASP Isotopes (ASPI.US)$ $GRI Bio (GRI.US)$ $Vast Renewables (VSTE.US)$ $MicroCloud Hologram (HOLO.US)$ $Theriva Biologics (TOVX.US)$ $Pluribus Technologies Corp (PLRB.CA)$ $Ensysce Biosciences (ENSC.US)$ $Athira (ATHA.US)$ $Globalstar (GSAT.US)$ $ChromaDex (CDXC.US)$
📊⚡️📊

Brandon Buckner

Nov 1 03:30

Beware

$Pro-Dex (PDEX.US)$ This is going to be shorted

Stock_Drift

Oct 31 17:38

After Hours Ticks. 6:36pm 🎃🎃🎃

$Trinity Biotech (TRIB.US)$ $Wag! Group (PET.US)$ $Ohmyhome (OMH.US)$ $Edesa Biotech (EDSA.US)$ $Tian Ruixiang (TIRX.US)$ $ChromaDex (CDXC.US)$ $Atlassian (TEAM.US)$ $ZW Data Action Tech (CNET.US)$ $Phoenix Motor (PEV.US)$ $Athira (ATHA.US)$ $Theriva Biologics (TOVX.US)$ $Pro-Dex (PDEX.US)$ $VS MEDIA Holdings (VSME.US)$
📊⚡️📊

Moomoo AI

Jan 26 04:49

Pro-Dex's low P/E ratio may be due to anticipated earnings fall, mirroring broader market trends. The company's shrinking earnings outlook is contributing to its low P/E. The low P/E and weak outlook could continue to pressure the shares unless conditions improve.